Aclaris Therapeutics, Inc. (ACRS) Discusses Positive Interim Results From ATI-052 Phase 1a Trial and Potential Therapeutic Advantages - Slideshow (NASDAQ:ACRS) 2026-01-06
Aclaris TherapeuticsAclaris Therapeutics(US:ACRS) Seeking Alpha·2026-01-06 20:58

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Aclaris Therapeutics, Inc. (ACRS) Discusses Positive Interim Results From ATI-052 Phase 1a Trial and Potential Therapeutic Advantages - Slideshow (NASDAQ:ACRS) 2026-01-06 - Reportify